Genomewide association studies have had some success in finding DNA variants associated with increased risk for bipolar disorder. But researchers from the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University in England have taken these studies a step further by looking for common functional themes running through the GWAS data. Their results, published online this month in the American Journal of Human Genetics, implicate some of the most basic biological pathways in the genesis of bipolar disorder.
Starting with the idea that the genetic variations increasing risk for a disorder are probably not randomly distributed throughout the genome, but instead are in one or more sets of related genes, Holmans et al. re-analyzed the SNP data from four previous studies that included a total of 4,387 cases of bipolar disorder and 6,209 controls. Researchers at the Children’s Hospital of Philadelphia recently took a similar approach (although the technical details of the analysis differ) for a study of Crohn’s disease.
The bipolar disorder researchers found that biological pathways involved in broad control of cellular activity were overrepresented in the genetic variations association with bipolar disorder. Two of the pathways, hormone activity and cellular self-digestion, are known to be impacted by lithium, the major medication used to treat bipolar disorder. As always, more research will be needed to substantiate these findings, as well as to understand how they can be used to help the more millions of people worldwide dealing with bipolar disorder.
(23andMe customers can learn more in the Bipolar Disorder Research Report and the Bipolar Disorder: Preliminary Research Report.)